Fratricidal retroviruses: a new twist in gene therapy.
Rabson
Arnold B
AB
Cancer Institute of New Jersey and Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854 USA. rabson@cabm.rutgers.edu
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002478:Cells, Cultured; D015967:Gene Expression Regulation, Viral; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D005256:Leukemia Virus, Feline / Q000502:physiology*; D011355:Prodrugs; D012192:Retroviridae Infections / Q000235:genetics / Q000628:therapy*; D015682:Retroviridae Proteins, Oncogenic / Q000235:genetics* / Q000378:metabolism; D019076:Transgenes; D014412:Tumor Virus Infections / Q000235:genetics / Q000628:therapy*; D014759:Viral Envelope Proteins / Q000235:genetics* / Q000378:metabolism; D014777:Virus Diseases / Q000628:therapy*; D014779:Virus Replication
D000998:Antiviral Agents; D011355:Prodrugs; D015682:Retroviridae Proteins, Oncogenic; D014759:Viral Envelope Proteins; C073723:glycoprotein gp70, Feline leukemia virus